Iminosugar Inhibitors for Substrate Reduction Therapy for the Lysosomal Glycosphingolipidoses
Terry D. Butters
Abstract
Terry D. Butters
Abstract
This chapter contains sections titled: Glycolipid lysosomal storage diseases Options for glycosphingolipidosis therapy Iminosugars for substrate reduction therapy Iminosugars as inhibitors of glycolipid biosynthesis SRT combination therapy Prospects for iminosugars as therapeutics References
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Glycolipid lysosomal storage diseases Options for glycosphingolipidosis therapy Iminosugars for substrate reduction therapy Iminosugars as inhibitors of glycolipid biosynthesis SRT combination therapy Prospects for iminosugars as therapeutics References
Key concepts: Iminosugar, Substrate reduction therapy, Glycolipid, Substrate (aquarium), Reduction (mathematics), Chemistry, Medicine, Biochemistry